e-Drug3D

403

FLUCYTOSINE


INN
FLUCYTOSINE

(has an active metabolite)

cas 2022-85-7
CLASS

ANTIINFECTIVES
ANTIFUNGAL
ANTIMETABOLITES

ROUTE (list)

ORAL

ATC code

D01AE21
J02AX01

PK parameters

F 83 PERCENT
Tmax 2 HOUR
VD 44.2 LITER (65 KILOGRAM)
Cl 7.8 LITER / HOUR (65 KILOGRAM)
PPB 4 PERCENT
t1/2 3.6 HOUR

Target

TARGET CYTOSINE DEAMINASE

DrugCentral

Thymidylate synthase UNIPROT P0CS13 TMP1

Thymidylate synthase UNIPROT P12461 TMP1

Download SDF file 4-amino-5-fluoro-3H-pyrimidin-2-one

Formula:
C4H4FN3O

Calculated chemical properties:

MW 129.10
NB_atoms 9
XLogP -0.51
PSA 65.639
NB_HD 3
NB_HA 4
fsp3 0.00
Lipinski(0=no;1=yes) 1

FDA
NDA 017001 (pdf not found) INN (FLUCYTOSINE) ANCOBON (BAUSCH) APPROVAL= AP YEAR= 1971
NDA 201566 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (SIGMAPHARM LABS LLC) APPROVAL= AP YEAR= 2011
NDA 204652 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (NOVEL LABS INC) APPROVAL= AP YEAR= 2017
NDA 206550 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (HIKMA) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 207536 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (STRIDES PHARMA) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 212632 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (STRIDES PHARMA) APPROVAL= AP YEAR= 2020
NDA 213665 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2020
NDA 218005 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (LAURUS) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL